The lack of increased angiogenesis as reflected by CD31 count and tumor hypoxia as reflected by CA9 expression, in the setting of treatment failure of cediranib, was contrasted by a statistically significant increase in p-STAT3 expressing macrophages. This evidence concerns the gene PECAM1 and neoplasm.